Navigation Links
Recovery Act funds expand studies of stem cell biology
Date:10/28/2009

The National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. These cells, abbreviated iPS, are reprogrammed from skin or other easily obtained adult cells and appear to be similar to stem cells derived from embryos.

In theory, iPS cells could generate any type of cell and be used to treat diseases. But to realize this potential, scientists need a much better understanding of iPS cells' fundamental properties and how to efficiently derive cells that are safe for therapeutic uses.

To speed iPS research, NIGMS has awarded one-year grant supplements to 22 scientists at 16 institutions in 12 states and the District of Columbia. The investigators already have strong records of accomplishment in a range of research areas and will study iPS cells in varied biological systems.

"Stem cell biology is poised for rapid advances, and we expect our Recovery Act investment to have a catalytic effect. The new awards will contribute to the field's progress by enhancing the utility of iPS cells as tools for research, for testing the effects of drugs on human tissues and ultimately for patient-specific treatments," said NIGMS Director Jeremy M. Berg, Ph.D.

The Recovery Act funding will allow the scientists to address such important questions as:

  • How does reprogramming work?
  • What factors are necessary to create iPS cells efficiently and safely?
  • What drives iPS cells toward a desired cell type that can be used to regenerate or repair damaged tissues in a patient?
  • Do iPS cells differ from embryonic and adult stem cells, and if so, how?

The investigators receiving supplements are:

  • Bruce Beutler, Scripps Research Institute, La Jolla, Calif.
  • C. Anthony Blau, University of Washington, Seattle
  • Richard Cerione, Cornell University, Ithaca, N.Y.
  • Stephen Dalton, University of Georgia, Athens
  • Sharon Dent, University of Texas M.D. Anderson Cancer Center, Houston
  • Andres Garcia, Georgia Institute of Technology, Atlanta
  • David Gilbert, Florida State University, Tallahassee
  • Margaret Goodell, Baylor College of Medicine, Houston
  • Brenton Graveley, University of Connecticut Health Center, Farmington
  • Jeanne Lawrence, University of Massachusetts Medical School, Worcester
  • Jeannie Lee, Massachusetts General Hospital, Boston
  • Shaohua Li, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, Piscataway
  • John Lis, Cornell University, Ithaca, N.Y.
  • Nancy Maizels, University of Washington, Seattle
  • Sergie Nekhai, Howard University, Washington, D.C.
  • Sean Palecek, University of Wisconsin-Madison
  • Arnold Rizzino, University of Nebraska Medical Center, Omaha
  • Hannele Ruohola-Baker, University of Washington, Seattle
  • James Thomson, University of Wisconsin-Madison
  • Yi Wang, Baylor College of Medicine, Houston
  • Jeffrey Wilusz, Colorado State University, Fort Collins
  • Jerome Zack, University of California, Los Angeles


'/>"/>

Contact: Ann Dieffenbach
dieffena@nigms.nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences
Source:Eurekalert  

Related biology news :

1. Survey finds elevated rates of new asthma among WTC rescue and recovery workers
2. New study shows greenback cutthroat trout involved in recovery effort misidentified
3. Recovery from acid rain much slower than expected
4. Diet and lifestyle critical to recovery, says study
5. Ozone hole recovery may reshape southern hemisphere climate change
6. Recovery efforts not enough for critically endangered Asian vulture
7. Diversity of plant-eating fishes may be key to recovery of coral reefs
8. Endangered sawfish focus of national collection and recovery efforts
9. Flowering plants speed post-surgery recovery
10. Long-term recovery of reefs from bleaching requires local action to increase resilience
11. Basic research critical to Americas economic recovery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Recovery Act funds expand studies of stem cell biology
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, ... launch of their brand, UP4™ Probiotics, into Target stores nationwide. The company, which ... to add Target to its list of well-respected retailers. This list includes such ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
Breaking Biology Technology: